Analysis of Programs and Guidelines on Traditional Chinese Medicine (TCM) for COVID-19 to Provide Suggestions for Future Development of TCM Clinical Practice Guidelines
10.13422/j.cnki.syfjx.20200841
- VernacularTitle:新型冠状病毒肺炎中医诊疗/防治方案对中医临床指南制定的思考
- Author:
Xue FENG
1
;
Xiao-jiao DUAN
1
;
Bing ZHANG
2
;
SARINA
2
;
Xiang-fei SU
1
;
Si-yuan MA
1
;
Yuan LI
1
;
Yu-bo GUO
1
Author Information
1. Standardization Department, China Association of Chinese Medicine, Beijing100029, China
2. Beijing University of Chinese Medicine, Beijing100029, China
- Publication Type:Research Article
- Keywords:
coronavirus disease 2019 (COVID-19);
tratidional Chinese medicine;
diagnosis and treatment program;
prevention and treatment program;
clinical practice guidelines
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(14):20-28
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To comprehensively analyze the diagnosis and treatment programs and prevention and treatment programs on tratidional Chinese medicine (TCM) for coronavirus disease-2019 (COVID-19), and to provide suggestions for further development of TCM clinical guidelines. Method:Diagnosis and treatment programs on TCM for COVID-19 pneumonia, as well as prevention and treatment programs, clinical practice guidelines and expert consensus, were retrieved till Feb 19, 2020. The information about TCM syndrome differentiation, state of disease, and TCM treatments (decoction and Chinese patent medicines) were extracted and analyzed. Result:A total of 24 TCM programs/guidelines were included containing 23 diagnosis and treatment programs or prevention and treatment programs and one rapid advice guideline. Of the 23 TCM programs, 14 programs described the classification of TCM syndromes and the stages of disease，22 programs described the composition of the TCM decoction; seven programs described how to add and subtract the herbs according to different TCM syndromes,17 programs described the weight/volume of the herbs of TCM decoctions, three programs described the decoction method，six programs described the usage and dosage of TCM decoction， two programs clarified the course of treatment; none of the 23 programs indicated the source of evidence. The TCM treatment within the rapid advice guideline was in reference to the fourth edition of the COVID-19 pneumonia TCM diagnosis and treatment program issued by the National Health Commission. A total of 41 Chinese patent medicines were recommended in 23 programs, of which 12 Chinese patent medicines were off-label recommended. Conclusion:In most TCM programs, TCM decoction and Chinese patent medicines are recommended based on TCM syndrome differentiation in combination with the state of disease, and the dosage of the TCM decoctions are clearly described. Some Chinese patent medicines in the TCM programs are off-label recommended. Expert experience and opinions are valued when developing TCM programs/ guidelines. All of these provide reference for developing TCM programs/guidelines in future.
